IMP: Resolution of Annual General Meeting 2019

Imexpharm Corporation announces the resolution of Annual General Meeting 2019, which was convened on April 23, 2019, as follows:

Article 1: Approving the report of the Board of Directors regarding business performance in 2018 and business plan for 2019.

Article 2: Approving the report of the Management Board.

Article 3: Approving the report of the Board of Supervisors.

Article 4: Approving the remuneration of the Board of Directors and the Board of Supervisors in 2018 and 2019.

Article 5: Approving the profit distribution plan for 2018 and the dividend payment for 2019.

Article 6: Approving to authorize the Board of Directors to choose an audit firm for auditing the listed company's financial statements in 2019.

Article 7: Approving the establishment and use of Investment Development Fund in 2019.

Article 8: This resolution shall take effect from April 23, 2019.

Please see the attached files.

HOSE

>   LAF: Resolution of Annual General Meeting 2019 (04/05/2019)

>   BID: Resolution on the AGM 2019 (04/05/2019)

>   S4A: Resolution on the 2019 AGM (04/05/2019)

>   DHG: Record date for 2019 AGM (04/05/2019)

>   TIE: Record date for 2019 AGM (04/05/2019)

>   DIC: Holding AGM 2019 (04/05/2019)

>   SJF: BOD resolution on the holding of AGM 2019 (04/05/2019)

>   API: Financial Statement Quarter 1/2019 (04/05/2019)

>   VEA: Notice of record date for General Meeting of Shareholders 2019 (04/05/2019)

>   SP2: Notice of record date for General Meeting of Shareholders 2019 (04/05/2019)